Patrick A Mayes insider trades

Open-market stock purchases and sales by Patrick A Mayes, EVP & Chief Scientific Officer at Incyte Corp, from SEC Form 4 filings since Oct 1, 2025.

Recent trades

DateStockTradeValue
Aug 5, 2026INCY Incyte CorpSold$274K
Aug 5, 2026INCY Incyte CorpBought (not open market)—
Aug 3, 2026INCY Incyte CorpSold$729K
Aug 3, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpSold$196K
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpSold$1.8M
Jul 31, 2026INCY Incyte CorpSold$637K
Jul 31, 2026INCY Incyte CorpSold$274K
Jul 31, 2026INCY Incyte CorpSold$737K
Jul 31, 2026INCY Incyte CorpSold$39.7K
Jul 31, 2026INCY Incyte CorpSold$10.4K
Jul 31, 2026INCY Incyte CorpSold$261K
Jul 31, 2026INCY Incyte CorpSold$561K
Jul 31, 2026INCY Incyte CorpSold$342K
Jul 31, 2026INCY Incyte CorpSold$196K
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—
Jul 31, 2026INCY Incyte CorpBought (not open market)—

Companies traded

  • INCY Incyte Corp: 15 sales, last Aug 5, 2026

Get free alerts when Patrick A Mayes files a new trade →